Dipeptidase Inhibitors [MoA] - N0000175513

  1. Home
  2. Pharmacologic Class Index
  3. Dipeptidase Inhibitors [MoA] - N0000175513

Pharmacologic Class Information

Pharmacologic Code N0000175513
Pharmacologic Name Dipeptidase Inhibitors
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Dipeptidase Inhibitors

The table contains 9 products whose active ingredient are classified under the same pharmacologic class Dipeptidase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-3516Primaxin IVNon-Proprietary Name: Imipenem And Cilastatin SodiumInjection, Powder, For SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
0006-3856Recarbrio Non-Proprietary Name: Imipenem Anhydrous, Cilastatin, And Relebactam AnhydrousInjection, Powder, For SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
44567-705Imipenem And Cilastatin Non-Proprietary Name: Imipenem And CilastatinInjection, Powder, For SolutionIntravenousWg Critical Care, LlcACTIVE
63323-322Imipenem And Cilastatin Non-Proprietary Name: Imipenem And Cilastatin SodiumInjection, Powder, For SolutionIntravenousFresenius Kabi Usa, LlcACTIVE
63323-349Imipenem And Cilastatin Non-Proprietary Name: Imipenem And Cilastatin SodiumInjection, Powder, For SolutionIntravenousFresenius Kabi Usa, LlcACTIVE